TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35292944

Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg twice daily)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Low dose aspirin (80 mg) and calcium (1 g) daily
Number of subjects: 173
Study: 33277284

Group type: EXPERIMENTAL
Intervention: Intravenous caffeine (20 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Enteral caffeine (20 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous caffeine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Enteral caffeine
Number of subjects: 40
Study: 35534081

Group type: EXPERIMENTAL
Intervention: Wilderness programme (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Holiday programme (n=20)
Number of subjects: 40
Study: 34230034

Group type: EXPERIMENTAL
Intervention: Integration of trial recruitment process into a clinical care pathway (CCP)
Number of subjects: 158
Study: 32469385

Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg/d for 36 months
Number of subjects: 400

Group type: COMPARATOR
Intervention: Imatinib 400 mg/d for 12 months
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Efficacy population (36-month group)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Efficacy population (12-month group)
Number of subjects: 400
Study: 35193873

Group type: EXPERIMENTAL
Intervention: MTX-hold (2-week methotrexate discontinuation after each vaccine dose)
Number of subjects: 138

Group type: COMPARATOR
Intervention: MTX-maintain (methotrexate maintenance)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: MTX-hold
Number of subjects: 138

Group type: COMPARATOR
Intervention: MTX-maintain
Number of subjects: 138
Study: 34789807

Group type: COMPARATOR
Intervention: Blephasteam (n=37)
Number of subjects: 70

Group type: COMPARATOR
Intervention: TheraPearl (n=33)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Comparison of Blephasteam and TheraPearl
Number of subjects: 70
Study: 32540150

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 49
Study: 36226886

Group type: EXPERIMENTAL
Intervention: Educational program on home birth
Number of subjects: 226

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 226
Study: 33129736

Group type: EXPERIMENTAL
Intervention: Breast density category A (lowest breast density)
Number of subjects: 3272

Group type: EXPERIMENTAL
Intervention: Breast density category B
Number of subjects: 3272

Group type: EXPERIMENTAL
Intervention: Breast density category C
Number of subjects: 3272

Group type: EXPERIMENTAL
Intervention: Breast density category D (highest breast density)
Number of subjects: 3272
Study: 32191506

Group type: EXPERIMENTAL
Intervention: 10% lidocaine, 10% prilocaine, and 4% tetracaine (experimental)
Number of subjects: 52

Group type: COMPARATOR
Intervention: 20% benzocaine (control)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 52
Study: 35219462

Group type: EXPERIMENTAL
Intervention: 3D-printed crowns with biocompatible light-curing composite
Number of subjects: 50

Group type: COMPARATOR
Intervention: Direct composite celluloid crowns
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 3D-printed crowns
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both crown types
Number of subjects: 50
Study: 33478652

Group type: COMPARATOR
Intervention: No compression (NONE)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lower leg compression (LEG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Abdominal/thigh compression (ABDO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Full abdominal/leg compression (FULL)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Compression garments (various types)
Number of subjects: 30
Study: 34700388

Group type: EXPERIMENTAL
Intervention: Nivolumab plus SABR (240mg nivolumab every 2 weeks + SABR 18-20 Gy on day 8-14 of cycle 1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nivolumab alone (240mg nivolumab every 2 weeks)
Number of subjects: 50
Study: 35639672

Group type: EXPERIMENTAL
Intervention: LifeBuoy (therapeutic smartphone application based on dialectical behavior therapy)
Number of subjects: 455

Group type: COMPARATOR
Intervention: LifeBuoy-C (attention-matched control application delivering general health information)
Number of subjects: 455
Study: 32640037

Group type: EXPERIMENTAL
Intervention: Nonparametric estimation and two-sample testing for population-averaged transition and state occupation probabilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonparametric cluster bootstrap
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Proposed methods for multistate models
Number of subjects: 0
Study: 32499466

Group type: EXPERIMENTAL
Intervention: 2 doses of 1.2 g amoxicillin‐clavulanic acid
Number of subjects: 160

Group type: COMPARATOR
Intervention: 7 days course of amoxicillin‐clavulanic acid and metronidazole
Number of subjects: 160
Study: 35785543

Group type: EXPERIMENTAL
Intervention: Social needs case management for 12 months
Number of subjects: 57972
Study: 34524031

Group type: EXPERIMENTAL
Intervention: All-arthroscopic (AA) rotator cuff repair
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Mini-open (MO) rotator cuff repair
Number of subjects: 274

Group type: COMPARATOR
Intervention: Both AA and MO rotator cuff repair
Number of subjects: 274
Study: 33305619

Group type: EXPERIMENTAL
Intervention: Early patient-directed rehabilitation (n=37); advised to remove their sling as soon as able and move as symptoms allow.
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard rehabilitation (n=36); sling immobilisation for four weeks.
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Follow-up at 12 weeks (both groups).
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Overall randomisation and follow-up measures.
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Serious adverse events reported.
Number of subjects: 73
Study: 33634628

Group type: EXPERIMENTAL
Intervention: Local infiltration with ropivacaine plus systemic analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline infiltration into the surgical wound plus systemic analgesia
Number of subjects: 0
Study: 35871321

Group type: EXPERIMENTAL
Intervention: Real cervical mobilization
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham mobilization
Number of subjects: 28
Study: 34635373

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM liquid presentation
Number of subjects: 979

Group type: COMPARATOR
Intervention: Currently licensed MenACWY-CRM vaccine presentation
Number of subjects: 979

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 979
Study: 35588504

Group type: EXPERIMENTAL
Intervention: Biologic mesh
Number of subjects: 108

Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 108
Study: 35217408

Group type: EXPERIMENTAL
Intervention: IPTp-SP
Number of subjects: 105

Group type: COMPARATOR
Intervention: IPTp-DP
Number of subjects: 105
Study: 32275000

Group type: EXPERIMENTAL
Intervention: Optimal PEEP guided by FRC
Number of subjects: 78

Group type: COMPARATOR
Intervention: Maximum oxygen monitoring (Control)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: FRC and trans-pulmonary pressure
Number of subjects: 78
Study: 35196147

Group type: EXPERIMENTAL
Intervention: Bandage contact lens soaked in 0.1% diclofenac
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal soft bandage contact lens (control)
Number of subjects: 51
Study: 34270328

Group type: EXPERIMENTAL
Intervention: Medtronic advanced hybrid closed‐loop (AHCL)
Number of subjects: 113

Group type: COMPARATOR
Intervention: First generation hybrid closed‐loop (HCL)
Number of subjects: 113
Study: 34128383

Group type: EXPERIMENTAL
Intervention: Neighborhood environment (crime)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Neighborhood environment (no streetlights)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Neighborhood environment (traffic)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Neighborhood environment (lack of nearby shops)
Number of subjects: 495

Group type: EXPERIMENTAL
Intervention: Neighborhood environment (no one out doing PA)
Number of subjects: 495
Study: 33811266

Group type: EXPERIMENTAL
Intervention: START intervention
Number of subjects: 176

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 176
Study: 35149125

Group type: EXPERIMENTAL
Intervention: Peg‐IFN‐α‐based therapy for 96 weeks with 24-week off-treatment follow-up
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Peg‐IFN‐α‐based therapy
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combination of HBcrAg <4 log10U/ml and HBsAb >2 log10IU/L at EOT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lower HBcrAg and higher HBsAb levels at EOT
Number of subjects: 80
Study: 34960153

Group type: EXPERIMENTAL
Intervention: Group D20SC 0‐1‐6
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Group D20CHO 0‐1‐6
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Group ND20SC 0‐1‐6
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Revaccination with one dose of hepatitis B vaccine containing 60 µg HBsAg
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Revaccination with one dose of hepatitis B vaccine containing 20 µg HBsAg
Number of subjects: 309
Study: 34489210

Group type: COMPARATOR
Intervention: Conventional radiotherapy (74 Gy/37 fractions/7.4 weeks)
Number of subjects: 3216

Group type: COMPARATOR
Intervention: Hypofractionated radiotherapy (60 Gy/20 fractions/4 weeks)
Number of subjects: 3216

Group type: COMPARATOR
Intervention: Hypofractionated radiotherapy (57 Gy/19 fractions/3.8 weeks)
Number of subjects: 3216

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (60 Gy)
Number of subjects: 3216

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (57 Gy)
Number of subjects: 3216

Group type: EXPERIMENTAL
Intervention: All schedules
Number of subjects: 3216
Study: 34791503

Group type: EXPERIMENTAL
Intervention: Peer-led oral health intervention based on Health Belief Model and Social Cognitive Theory
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1184
Study: 33678183

Group type: EXPERIMENTAL
Intervention: 1 ml ABHR volume
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: 2 ml ABHR volume
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: 3 ml ABHR volume
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: 1.5 ml ABHR volume
Number of subjects: 356

Group type: EXPERIMENTAL
Intervention: 3.5 ml or more ABHR volume
Number of subjects: 356
Study: 32527167

Group type: EXPERIMENTAL
Intervention: CO2 laser vaporization
Number of subjects: 16

Group type: COMPARATOR
Intervention: Stripping technique (laparoscopic decapsulation)
Number of subjects: 16
Study: 35888587

Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation combined with point-light display observation (2 times per day for 5 min, 3 days a week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional rehabilitation treatment (2 sessions per day for 90 min, 5 days a week)
Number of subjects: 0
Study: 34314392

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5%
Number of subjects: 144

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 144
Study: 35963072

Group type: EXPERIMENTAL
Intervention: 8-week integrated childbirth education program including simulation-based learning and mindfulness techniques (n = 53)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual standard prenatal care (n = 53)
Number of subjects: 106
Study: 32702190

Group type: EXPERIMENTAL
Intervention: Studies with progression-free survival as primary endpoint
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Studies with response rate as primary endpoint
Number of subjects: 0

Group type: COMPARATOR
Intervention: Studies for non-lead indication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Studies for first-line therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Studies without strong prior evidence listed
Number of subjects: 0
Study: 34341905

Group type: EXPERIMENTAL
Intervention: NTRK-fusion positive MDACC patients
Number of subjects: 199

Group type: COMPARATOR
Intervention: NTRK-fusion negative TCGA patients
Number of subjects: 199
Study: 34452979

Group type: EXPERIMENTAL
Intervention: Presence of normal fidgety movements (FMs)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Higher motor optimality score-revised (MOS-R)
Number of subjects: 118
Study: 35410967

Group type: EXPERIMENTAL
Intervention: Prednisolone (15 mg/m2 daily for 6 days)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study: 32147337

Group type: EXPERIMENTAL
Intervention: Screw fixation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cortical suture button fixation
Number of subjects: 18
Study: 34665573

Group type: EXPERIMENTAL
Intervention: CFHealthHub intervention (nebuliser with electronic monitoring, data transfer to digital platform, adherence monitoring via app, support from trained interventionist)
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: CFHealthHub intervention
Number of subjects: 608

Group type: COMPARATOR
Intervention: Usual care (clinic visits every 3 months)
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Economic modelling of CFHealthHub intervention
Number of subjects: 608
Study: 33590829

Group type: EXPERIMENTAL
Intervention: Upadacitinib (15 mg QD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adalimumab (40 mg EOW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib vs Adalimumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upadacitinib
Number of subjects: 0
Study: 33371023

Group type: EXPERIMENTAL
Intervention: Physitrack online exercise prescription tool
Number of subjects: 54

Group type: COMPARATOR
Intervention: Traditional paper-based methods
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups (Physitrack and paper-based)
Number of subjects: 54
Study: 35101942

Group type: EXPERIMENTAL
Intervention: Anti-PD-1 monotherapy (first-line and second-line)
Number of subjects: 0
Study: 33798819

Group type: EXPERIMENTAL
Intervention: Deep-learning convolution neural network (DL-CNN) system for differentiating NMIBC and MIBC on contrast-enhanced CT images.
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Deep learning algorithms with pretrained bases from ImageNet dataset.
Number of subjects: 369
Study: 32546251

Group type: EXPERIMENTAL
Intervention: Reh@City v2.0 (adaptive cognitive training through everyday tasks VR simulations)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Task Generator (TG: content equivalent and adaptive paper-and-pencil training)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Reh@City v2.0
Number of subjects: 36
Study: 33768775

Group type: EXPERIMENTAL
Intervention: Eccentric isokinetic training
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Concentric isokinetic training
Number of subjects: 63

Group type: COMPARATOR
Intervention: Resistance bands training
Number of subjects: 63
Study: 33308423

Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 testing (self-swabs)
Number of subjects: 280327

Group type: EXPERIMENTAL
Intervention: Age group (17-24 years)
Number of subjects: 280327

Group type: EXPERIMENTAL
Intervention: Risk factors (patient-facing role, working outside home)
Number of subjects: 280327

Group type: EXPERIMENTAL
Intervention: Symptom reporting
Number of subjects: 280327
Study: 33409669

Group type: EXPERIMENTAL
Intervention: Genetically predicted higher educational attainment
Number of subjects: 655666

Group type: EXPERIMENTAL
Intervention: Cognitive performance
Number of subjects: 655666

Group type: EXPERIMENTAL
Intervention: More years of education
Number of subjects: 655666

Group type: COMPARATOR
Intervention: Cognitive performance (after controlling for educational attainment)
Number of subjects: 655666
Study: 35526026

Group type: EXPERIMENTAL
Intervention: Tanreqing oral liquid, 20 mL three times daily for seven consecutive days
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo oral liquid, 20 mL three times daily for seven consecutive days
Number of subjects: 270
Study: 34891146

Group type: EXPERIMENTAL
Intervention: Audio labeling of images
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Visual labeling of images
Number of subjects: 11
Study: 33203708

Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Passive surveillance
Number of subjects: 2500
Study: 35276914

Group type: EXPERIMENTAL
Intervention: Lactococcus lactis strain Plasma (LC‐Plasma) administered as a beverage (1.0 × 10^11 count LC‐Plasma/day/person)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactococcus lactis strain Plasma (LC‐Plasma)
Number of subjects: 0
Study: 33522066

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound-guided puncture-aspiration (TUGPA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional conservative surgery (CS)
Number of subjects: 150
Study: 33101559

Group type: EXPERIMENTAL
Intervention: LED light therapy with electromagnetic field (MLT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cryotherapy (CT)
Number of subjects: 60
Study: 36293616

Group type: EXPERIMENTAL
Intervention: Very Low-Calorie Ketogenic diet (VLCKD)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 268
Study: 34425585

Group type: EXPERIMENTAL
Intervention: 30-minute application of 4% hydrogen peroxide
Number of subjects: 92

Group type: COMPARATOR
Intervention: 120-minute application of 4% hydrogen peroxide
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 92
Study: 33689656

Group type: EXPERIMENTAL
Intervention: Dual-focus contact lens (MiSight)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Monofocal contact lens (Proclear 1-day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Baseline (naked eye condition)
Number of subjects: 28
Study: 34500022

Group type: EXPERIMENTAL
Intervention: MI‐SCA patients
Number of subjects: 6849

Group type: EXPERIMENTAL
Intervention: MI‐SCA patients after ICD implantation
Number of subjects: 6849

Group type: COMPARATOR
Intervention: MI‐SCA patients without ICD implantation
Number of subjects: 6849
Study: 34982369

Group type: EXPERIMENTAL
Intervention: TT (TACE)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Non-TT (TACE + Sora)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-TT (TACE)
Number of subjects: 84
Study: 33612629

Group type: EXPERIMENTAL
Intervention: Nutrition Education (NE)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Multi-Nutrient Biscuit (MNB)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Combination of Nutrition Education and Multi-Nutrient Biscuits (NE+MNB)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 121
Study: 33592624

Group type: EXPERIMENTAL
Intervention: Brief Alcohol Interventions (BAIs) including Motivational Interviewing with Personalized Feedback (MI + PF), Group Motivational Interviewing (GMI), and stand-alone Personalized Feedback (PF)
Number of subjects: 6801

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 6801
Study: 33023221

Group type: COMPARATOR
Intervention: Low Protein (LP) - 15 g protein
Number of subjects: 26

Group type: COMPARATOR
Intervention: Medium Protein (MP) - 30 g protein
Number of subjects: 26

Group type: COMPARATOR
Intervention: High Protein (HP) - 45 g protein
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control - 7 g protein
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (experiment 2)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: High Protein (HP) (experiment 2)
Number of subjects: 26
Study: 35988911

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo + Exercise (PLA + EX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Protein (PRO)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Protein + Exercise (PRO + EX)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Protein ingestion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10
Study: 33615957

Group type: EXPERIMENTAL
Intervention: Combined therapy with cTACE + MWA (Group 3)
Number of subjects: 265

Group type: COMPARATOR
Intervention: TACE (Group 1)
Number of subjects: 265

Group type: COMPARATOR
Intervention: MWA (Group 2)
Number of subjects: 265
Study: 33794965

Group type: EXPERIMENTAL
Intervention: Mosquito Magnet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Human Landing Catch (HLC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Human Baited Trap (HBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CDC Light Trap
Number of subjects: 0
Study: 33371155

Group type: EXPERIMENTAL
Intervention: Acupuncture group (AG)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Sham acupuncture group (NAG)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Waiting-list group (WLG)
Number of subjects: 360
Study: 35865817

Group type: EXPERIMENTAL
Intervention: Empirical intravenous antibiotic therapy during endotherapy (Group 1)
Number of subjects: 62

Group type: COMPARATOR
Intervention: No antibiotic therapy during endoscopic drainage (Group 2)
Number of subjects: 62
Study: 33600025

Group type: COMPARATOR
Intervention: Conventional pulmonary vein isolation (PVI) ablation
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: PVI + fibrosis-guided ablation
Number of subjects: 900
Study: 32068463

Group type: EXPERIMENTAL
Intervention: Unrestricted cycling during hemodialysis (condition 1)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cycling with blood flow restriction while off hemodialysis (condition 2)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cycling with blood flow restriction during hemodialysis (condition 3)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Blood flow restriction during aerobic exercise
Number of subjects: 10
Study: 35585484

Group type: EXPERIMENTAL
Intervention: Multimodal intervention consisting of individualized assessment, transition navigator, virtual patient skills-building, and virtual structured education program.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care defined by each participating center (Control group).
Number of subjects: 0
Study: 35578271

Group type: EXPERIMENTAL
Intervention: Heparin administration with a target of 2–2.5 times baseline aPTT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heparin administration with a target of 1.5–2 times baseline aPTT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin guided by weight and renal function
Number of subjects: 0